Clinical Trial Update: Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 non-inferiority trial comparing PRO-067 ophthalmic solution to Ofteno in primary open-angle glaucoma and ocular hypertension was terminated; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Ofteno
• PRO-067 Ophthalmic Solution (PRO-067 ophthalmic solution)

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: TERMINATED | Results posted: 2019-10-28